{"id":4771,"date":"2026-05-06T09:12:32","date_gmt":"2026-05-06T07:12:32","guid":{"rendered":"https:\/\/ksbbiotech.com\/?page_id=4771"},"modified":"2026-06-01T14:07:25","modified_gmt":"2026-06-01T12:07:25","slug":"d-dimer","status":"publish","type":"page","link":"https:\/\/ksbbiotech.com\/zh\/d-dimer\/","title":{"rendered":"D-\u4e8c\u805a\u4f53"},"content":{"rendered":"\t\t
PDB ID: 2Q9I. Source: RCSB Protein Data Bank. For illustration purposes only.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
The VeriLumenTM<\/sup> D-Dimer\u00a0Rapid Test is a fluorescence immunochromatographic assay for the quantitative detection of D-dimer in human whole blood or plasma samples. D-dimer is a fibrin degradation fragment produced during clot formation and breakdown, and elevated levels reflect activation of coagulation and fibrinolytic pathways. The assay provides rapid quantitative results to support timely clinical evaluation in laboratory and point-of-care settings.<\/p> This test is mainly used in the clinical assessment of coagulation and thrombotic disorders, including disseminated intravascular coagulation (DIC), and is also valuable in the evaluation of suspected venous thromboembolism such as deep vein thrombosis (DVT) and pulmonary embolism (PE), helping to support clinical decision pathways. It may additionally be used in the monitoring of thrombolytic therapy. Quantitative D-dimer measurement supports clinical interpretation when considered alongside other laboratory and clinical findings.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t